| 前收市價 | 5.0600 |
| 開市 | 4.7500 |
| 買盤 | 5.3000 |
| 賣出價 | 5.5000 |
| 拍板 | 185.00 |
| 到期日 | 2025-01-17 |
| 今日波幅 | 4.6300 - 4.8600 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 2.81k |
ZacksAbbVie (ABBV) Laps the Stock Market: Here's Why
AbbVie (ABBV) closed the most recent trading day at $170.46, moving +0.61% from the previous trading session.
ZacksPharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval
Eli Lilly's (LLY) CFO Anat Ashkenazi resigns. CHMP recommends the expanded use of AbbVie's (ABBV) Skyrizi and AstraZeneca's (AZN) Tagrisso.
ZacksAbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
Data from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective response rate of almost 52% in certain heavily pre-treated patients with ovarian cancer.
